ArticleFrontiers in human neuroscience2026
Longitudinal neural and psychological changes following psilocybin under compassion imagery priming.
Article in Frontiers in human neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Psilocybin is a classic psychedelic known to alter subjective experience and induce lasting psychological changes, including increased cognitive flexibility and reduced rigid self-related beliefs. Contextual factors, including preparatory mental states, are thought to play a key role in shaping these effects. Compassion imagery, which engages care-affiliative motivational systems, may represent a promising priming approach in this context. Here, we investigated the neural and psychological effects of psilocybin under compassion imagery priming using self-report questionnaires and functional magnetic resonance imaging (fMRI) in a naturalistic sample of 105 participants. Participants were primed with either compassion imagery or attention to breathing prior to psilocybin intake. We observed sustained increases in absorption over time, particularly in the high-dose compassion imagery condition. Additional within-group increases were found in measures of decentering and self-compassion. Using functional connectivity features, fMRI-based classifiers distinguished between resting state and compassion imagery conditions prior to intake, and between priming conditions following psilocybin, with significant classification performance observed only in the high-dose group. These findings suggest that psilocybin is associated with lasting changes in absorption and may be modulated by contextual priming to shape both psychological outcomes and large-scale brain network dynamics. More generally, our results highlight the potential role of compassion-based practices as preparatory interventions in psychedelic contexts. Future confirmatory studies are needed to further characterize these effects and their underlying mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.